2 completed, 2 not yet recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Piclidenoson: new trials by email Literature Review of Piclidenoson trials Research Report on Piclidenoson
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome Piclidenoson - Lowe Syndrome | Phase 2 | Not yet recruiting | Can-Fite BioPharma | 5 | 2026-06-01 | 2026-02-18 |
| A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy piclidenoson, Placebo - Plaque Psoriasis | Phase 3 | Not yet recruiting | Can-Fite BioPharma | 705 | 2025-06-01 | 2025-04-29 |
| Piclidenoson for Treatment of COVID-19 Piclidenoson, Placebo - COVID-19, Coronavirus Infection | Phase 2 | Completed | Can-Fite BioPharma | 6 | 2021-01-06 | 2022-04-22 |
| Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca CF101, Placebo - Keratoconjunctivitis Sicca | Phase 2 | Completed | Can-Fite BioPharma | 80 | 2007-01-01 | 2022-05-09 |
COVID-19 (1) · Coronavirus Infections (1) · Dry Eye Syndromes (1) · Keratoconjunctivitis Sicca (1) · Oculocerebrorenal Syndrome (1) · Psoriasis (1)
Israel (2) · Bulgaria (1) · Italy (1) · Romania (1)
Irit Bareket, MD (1) · Zivit Harpaz (1)